AU2005204365A1 - Compositions comprising memantine and polyanionic polymers for administration to the eye - Google Patents
Compositions comprising memantine and polyanionic polymers for administration to the eye Download PDFInfo
- Publication number
- AU2005204365A1 AU2005204365A1 AU2005204365A AU2005204365A AU2005204365A1 AU 2005204365 A1 AU2005204365 A1 AU 2005204365A1 AU 2005204365 A AU2005204365 A AU 2005204365A AU 2005204365 A AU2005204365 A AU 2005204365A AU 2005204365 A1 AU2005204365 A1 AU 2005204365A1
- Authority
- AU
- Australia
- Prior art keywords
- component
- eye
- adamantane
- composition
- memantine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/752,125 US20050147584A1 (en) | 2004-01-05 | 2004-01-05 | Compositions and methods comprising memantine and polyanionic polymers |
| US10/752,125 | 2004-01-05 | ||
| US10/941,272 US20050031652A1 (en) | 2003-02-25 | 2004-09-14 | Compositions and methods comprising memantine and polyanionic polymers |
| US10/941,272 | 2004-09-14 | ||
| PCT/US2005/000249 WO2005067891A1 (en) | 2004-01-05 | 2005-01-04 | Compositions comprosing memantine and polyanionic polymers for administration to the eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005204365A1 true AU2005204365A1 (en) | 2005-07-28 |
Family
ID=34798997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005204365A Abandoned AU2005204365A1 (en) | 2004-01-05 | 2005-01-04 | Compositions comprising memantine and polyanionic polymers for administration to the eye |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050031652A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1701700A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2007517885A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2005204365A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BRPI0506689A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2552521A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005067891A1 (cg-RX-API-DMAC10.html) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293737B2 (en) | 2006-10-16 | 2012-10-23 | Bionomics Limited | Anxiolytic compounds |
| US9023848B2 (en) | 2011-03-02 | 2015-05-05 | Bionomics Limited | Small-molecules as therapeutics |
| US9133188B2 (en) | 2011-05-12 | 2015-09-15 | Bionomics Limited | Methods for preparing naphthyridines |
| US10954231B2 (en) | 2006-10-16 | 2021-03-23 | Bionomics Limited | Anxiolytic compounds |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050009884A1 (en) * | 1997-06-30 | 2005-01-13 | Dreyer Evan B. | Calcium blockers to treat proliferative retinal diseases |
| JP2002182418A (ja) * | 2000-12-11 | 2002-06-26 | Konica Corp | 画像形成方法、画像形成装置 |
| US20080033053A1 (en) * | 2004-07-22 | 2008-02-07 | Wolfgang Curt D | Cross-Reference To Related Applications |
| JP2008507588A (ja) * | 2004-07-26 | 2008-03-13 | アラーガン、インコーポレイテッド | 眼の病態を処置する方法 |
| US20070167527A1 (en) * | 2006-01-13 | 2007-07-19 | Burke James A | Memantine for the normalization of visual acuity deficits |
| WO2008098027A2 (en) * | 2007-02-06 | 2008-08-14 | Allergan, Inc. | Treatment of ischemic retinal conditions with memantine |
| WO2011071995A2 (en) | 2009-12-08 | 2011-06-16 | Case Western Reserve University | Compounds and methods of treating ocular disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554367A (en) * | 1984-10-31 | 1996-09-10 | Alcon Laboratories, Inc. | Compositions for treatment of glaucoma |
| US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| US4738851A (en) * | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| US5008242A (en) * | 1986-12-24 | 1991-04-16 | John Lezdey | Treatment of inflammation using 1-antichymotrypsin |
| US5221696A (en) * | 1989-03-29 | 1993-06-22 | Alcon Laboratories, Inc. | Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs |
| US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
| US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
| US5691316A (en) * | 1994-06-01 | 1997-11-25 | Hybridon, Inc. | Cyclodextrin cellular delivery system for oligonucleotides |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6380261B1 (en) * | 1997-06-30 | 2002-04-30 | Allergan Sales, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
| AU761824B2 (en) * | 1998-10-27 | 2003-06-12 | Alcon Laboratories, Inc. | Treatment of disorders of the outer retina |
| US6258350B1 (en) * | 1999-01-20 | 2001-07-10 | Alcon Manufacturing, Ltd. | Sustained release ophthalmic formulation |
| CA2368242A1 (en) * | 1999-03-12 | 2000-09-21 | Alcon Laboratories, Inc. | Combination therapy for treating glaucoma |
| US6482854B1 (en) * | 1999-03-25 | 2002-11-19 | Massachusetts Eye And Ear Infirmary | Glaucoma treatment |
| SK282717B6 (sk) * | 2000-03-10 | 2002-11-06 | �Stav Experiment�Lnej Farmakol�Gie Sav | Spôsob prípravy ultravysokomolekulových hyalurónanov |
| US6572849B2 (en) * | 2000-09-20 | 2003-06-03 | Lee Shahinian, Jr. | Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
| US6761694B2 (en) * | 2001-12-13 | 2004-07-13 | Allergan, Inc. | Methods for measuring retinal damage |
| US6982079B2 (en) * | 2002-04-26 | 2006-01-03 | Allergan, Inc. | Compositions for treating hyperemia |
| EP1654002B2 (en) * | 2003-08-07 | 2014-01-29 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes |
-
2004
- 2004-09-14 US US10/941,272 patent/US20050031652A1/en not_active Abandoned
-
2005
- 2005-01-04 WO PCT/US2005/000249 patent/WO2005067891A1/en not_active Ceased
- 2005-01-04 EP EP05705052A patent/EP1701700A1/en not_active Withdrawn
- 2005-01-04 CA CA002552521A patent/CA2552521A1/en not_active Abandoned
- 2005-01-04 JP JP2006549374A patent/JP2007517885A/ja not_active Withdrawn
- 2005-01-04 AU AU2005204365A patent/AU2005204365A1/en not_active Abandoned
- 2005-01-04 BR BRPI0506689-1A patent/BRPI0506689A/pt not_active IP Right Cessation
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293737B2 (en) | 2006-10-16 | 2012-10-23 | Bionomics Limited | Anxiolytic compounds |
| US8551990B2 (en) | 2006-10-16 | 2013-10-08 | Bionomics Limited | Anxiolytic compounds |
| US8614212B2 (en) | 2006-10-16 | 2013-12-24 | Bionomics Limited | Anxiolytic compounds |
| US8906912B2 (en) | 2006-10-16 | 2014-12-09 | Bionomics Limited | Anxiolytic compounds |
| US9573945B2 (en) | 2006-10-16 | 2017-02-21 | Bionomics Limited | Anxiolytic compounds |
| US9975892B2 (en) | 2006-10-16 | 2018-05-22 | Bionomics Limited | Anxiolytic compounds |
| US10233181B2 (en) | 2006-10-16 | 2019-03-19 | Bionomics Limited | Anxiolytic compounds |
| US10954231B2 (en) | 2006-10-16 | 2021-03-23 | Bionomics Limited | Anxiolytic compounds |
| US9023848B2 (en) | 2011-03-02 | 2015-05-05 | Bionomics Limited | Small-molecules as therapeutics |
| US9133188B2 (en) | 2011-05-12 | 2015-09-15 | Bionomics Limited | Methods for preparing naphthyridines |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005067891A1 (en) | 2005-07-28 |
| JP2007517885A (ja) | 2007-07-05 |
| US20050031652A1 (en) | 2005-02-10 |
| BRPI0506689A (pt) | 2007-05-02 |
| CA2552521A1 (en) | 2005-07-28 |
| EP1701700A1 (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12409175B2 (en) | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | |
| US8299124B2 (en) | Aqueous intraocular penetration-promoting eye drop | |
| RU2744570C2 (ru) | Фармацевтическая композиция на основе трамадола для офтальмологического применения | |
| KR20080011310A (ko) | 폴록사머 또는 메록사폴 계면활성제 및 글리콜을유효성분으로 함유하는 현탁제, 안질환 치료용 의약의제조를 위한 그의 용도 | |
| KR20160126983A (ko) | 안내 혈관신생 및/또는 누출 치료용 조성물 및 방법 | |
| CN103747786A (zh) | 比马前列素和溴莫尼定的固定剂量组合 | |
| MX2014012158A (es) | Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico. | |
| AU2006244245B2 (en) | Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders | |
| US20050031652A1 (en) | Compositions and methods comprising memantine and polyanionic polymers | |
| JP2005533087A (ja) | 神経損傷の処置にリアノジン拮抗剤を用いる方法 | |
| CA3001957C (en) | Ophthalmic solution of difluprednate | |
| EP3749294A1 (en) | Formulations comprising chelators, permeation enhancers and hydroxyethyl cellulose for treating ophthalmic disorders | |
| JPH06316519A (ja) | 薬剤で誘導される瞳孔拡大を抑制し又は拡大された瞳孔を 縮小するための、一定のスルファモイル置換フェネチルア ミン誘導体の使用、及びそれに用いる局部的投与組成物 | |
| JP2008517937A (ja) | 眼科用組成物及びその使用方法 | |
| WO2019024433A1 (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
| US20050277698A1 (en) | Memantine delivery to the back of the eye | |
| WO2002040028A1 (fr) | Gouttes pour les yeux en gel antibacterien | |
| US20050147584A1 (en) | Compositions and methods comprising memantine and polyanionic polymers | |
| JP2024501425A (ja) | 眼炎症の有害作用を軽減するためのジフルプレドナート | |
| WO2025040941A1 (en) | Ophthalmic pharmaceutical compositions containing dorzolamide, methods for their preparation, and for their use | |
| EP0607697A2 (en) | DILAZEP for reduction of elevated intraocular pressure | |
| CA3036474A1 (en) | Therapeutic agent for an ophthalmic disease comprising a vegf receptor inhibitor | |
| HK40029199A (en) | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | |
| JPH02255618A (ja) | 緑内障治療剤 | |
| HK1174858A (en) | Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ COMPOSITIONS COMPRISING MEMANTINEAND POLYANIONIC POLYMERS FOR ADMINISTRATION TO THE EYE |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |